BupropionQTc Prolongation following off label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1894卷 / 1期

关键词：

D O I：

10.1007/s40278-022-10197-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：84 / 84

相关论文

共 50 条

[1] Atazanavir/ritonavirQTc prolongation following off-label treatment: case report
[J]. Reactions Weekly, 2021, 1862 (1) : 76 - 76
[2] ChloroquineQTc prolongation following off-label use: case report
[J]. Reactions Weekly, 2022, 1905 (1) : 159 - 159
[3] HydroxychloroquineQTc prolongation following off-label use: case report
[J]. Reactions Weekly, 2020, 1829 (1) : 196 - 196
[4] HydroxychloroquineQTc prolongation following off-label-use: case report
[J]. Reactions Weekly, 2020, 1811 (1) : 142 - 142
[5] Azithromycin/hydroxychloroquineQT prolongation following off label use: case report
[J]. Reactions Weekly, 2022, 1896 (1) : 80 - 80
[6] DelamanidVentricular bigeminy and QTc prolongation following off label use: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 178 - 178
[7] HydroxychloroquineQT interval prolongation following off-label use: case report
[J]. Reactions Weekly, 2022, 1901 (1) : 267 - 267
[8] HydroxychloroquineQTc-prolongation following an off-label use: case report
[J]. Reactions Weekly, 2020, 1829 (1) : 197 - 197
[9] RisperidoneQTc prolongation following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2020, 1805 (1) : 265 - 265
[10] OxaliplatinFever following off label treatment: case report
[J]. Reactions Weekly, 2022, 1898 (1) : 317 - 317

← 1 2 3 4 5 →